Paper22335359
The potential of bifidobacteria as a source of natural folate.
D'Aimmo MR and 4 others. J Appl Microbiol, 2012. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. The potential of bifidobacteria as a source of natural folate. Papers, record 22335359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22335359
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bifidobacterium | Major topic |
| Folic Acid | Major topic |
| Intestines | Major topic |
| Animals | |
| Chromatography, High Pressure Liquid | |
| Culture Media | |
| Dairy Products | |
| Fermentation | |
| Humans | |
| Intestinal Mucosa | |
| Metagenome | |
| Probiotics |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42694526 | Isolation of folate-producing probiotic candidates and their effects on homocysteine metabolism and gut microbiota composition. | Front Nutr | 2026 | https://conductscience.org/library/papers/42694526 | PubMed |
| 42494622 | Folate-Containing Fermented Foods of Plant and Animal Origin: The Value of Traditional Foods to Tackle Folate Deficiency. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42494622 | PubMed |
| 42278572 | A Systematic Review of Folate and the Human Enteric Microbiome: Biological Mechanisms and Clinical Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278572 | PubMed |
| 41769651 | Bifidobacterium supplementation maintains gut microbiota stability and enhances well-being during short-term travel. | Front Nutr | 2026 | https://conductscience.org/library/papers/41769651 | PubMed |
| 41284145 | Toward stabilization of bioactive folate produced by indigenous lactic acid bacteria via BSA complexation. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41284145 | PubMed |
| 40172109 | Vitamin biosynthesis in the gut: interplay between mammalian host and its resident microbiota. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/40172109 | PubMed |
| 40116950 | Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions. | Appl Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40116950 | PubMed |
| 40075081 | Biological, dietetic and pharmacological properties of vitamin B9. | NPJ Sci Food | 2025 | https://conductscience.org/library/papers/40075081 | PubMed |
| 39819813 | Core microbe Bifidobacterium in the hindgut of calves improves the growth phenotype of young hosts by regulating microbial functions and host metabolism. | Microbiome | 2025 | https://conductscience.org/library/papers/39819813 | PubMed |
| 38792843 | Probiotics in the New Era of Human Milk Oligosaccharides (HMOs): HMO Utilization and Beneficial Effects of Bifidobacterium longum subsp. infantis M-63 on Infant Health. | Microorganisms | 2024 | https://conductscience.org/library/papers/38792843 | PubMed |
| 38455078 | Folate-producing bifidobacteria: metabolism, genetics, and relevance. | Microbiome Res Rep | 2024 | https://conductscience.org/library/papers/38455078 | PubMed |
| 38188086 | Hypothetical Regulation of Folate Biosynthesis and Strategies for Folate Overproduction in Lactic Acid Bacteria. | Prev Nutr Food Sci | 2023 | https://conductscience.org/library/papers/38188086 | PubMed |
| 38046824 | Bifidobacterium in anticancer immunochemotherapy: friend or foe? | Microbiome Res Rep | 2023 | https://conductscience.org/library/papers/38046824 | PubMed |
| 37979040 | Bifidobacteria in Fermented Dairy Foods: A Health Beneficial Outlook. | Probiotics Antimicrob Proteins | 2025 | https://conductscience.org/library/papers/37979040 | PubMed |
| 37446182 | Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446182 | PubMed |
| 35662952 | Bacillus velezensis EEAM 10B Strengthens Nutrient Metabolic Process in Black Soldier Fly Larvae (Hermetia illucens) via Changing Gut Microbiome and Metabolic Pathways. | Front Nutr | 2022 | https://conductscience.org/library/papers/35662952 | PubMed |
| 34887435 | Identifying the essential nutritional requirements of the probiotic bacteria Bifidobacterium animalis and Bifidobacterium longum through genome-scale modeling. | NPJ Syst Biol Appl | 2021 | https://conductscience.org/library/papers/34887435 | PubMed |
| 34578878 | Probiotic Supplementation and Micronutrient Status in Healthy Subjects: A Systematic Review of Clinical Trials. | Nutrients | 2021 | https://conductscience.org/library/papers/34578878 | PubMed |
| 34469198 | Building Robust Assemblages of Bacteria in the Human Gut in Early Life. | Appl Environ Microbiol | 2021 | https://conductscience.org/library/papers/34469198 | PubMed |
| 34463576 | Abundance and Compositions of B-Vitamin-Producing Microbes in the Mammalian Gut Vary Based on Feeding Strategies. | mSystems | 2021 | https://conductscience.org/library/papers/34463576 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22335359
GET https://conductscience.org/api/papers/v1/22335359/cited_by?page=2